Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention defict hyperactivity disorder (ADHD)

Nutritional Neuroscience

Volumn 10, Issue 1-2, 2007, Pages 1-9

  Germano, Michele ^a   Meleleo, Domenico ^b   Montorfano, Gigliola ^c   Adorni, Laura ^c   Negroni, Manuela ^c   Berra, Bruno ^c   Rizzo, Angela M ^c  

^a NPI IRCS   (Italy)

^b Pediatra di Libera Scelta   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

AA EPA; ADHD; Cell membrane; Clinical improvement; Fatty acid; Omega 3

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ENERVIT; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BODY MASS; BODY WEIGHT; BRAIN DEVELOPMENT; BRAIN FUNCTION; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG WITHDRAWAL; ERYTHROCYTE; FEMALE; HUMAN; LEARNING DISORDER; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PLASMA CELL; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK FACTOR;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; PATIENT SELECTION; PHOSPHOLIPIDS; PILOT PROJECTS;

EID: 34247586105     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/10284150601153801     Document Type: Article

References (56)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, American Psychiatryc Press, Washington, DC
2. Anderson, RE and Sperling, L. (1971) Positional distribution of the fatty acids in the phospholipids of bovine retina rod outer segments. Arch Biochem Biophys, 144, pp. 673-677.
3. Armstrong, VT, Brzustowicz, MR, Wassal, SR, Jenski, LJ and Stillwell, W. (2003) Rapid flip-flop in polyunsaturated (docosahexaenoate) phospholipid membranes. Arch Biochem Biophys, 414, pp. 74-82.
4. Barkley, RA (1998) Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, Guilford, New York
5. Brown, RT, Freeman, WS, Perrin, JM, Stein, MT, Amler, RW, Feldman, HM, Pierce, K. and Wolraich, ML (2001) Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics, 107, pp. 43-54.
6. Burgess, JR, Stevens, L., Zhang, W. and Peck, L. (2000) Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr, 71, pp. 327S-330S.
7. Cacciari, E., Milani, S., Balsamo, A., Dammacco, F., De Luca, F., Chiarelli, F., Pasquino, AM, Tonini, G. and Vanelli, M. (2002) Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr, 56, pp. 171-180.
8. Calder, PC (2003) N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids, 38, pp. 343-352.
9. Castellanos, FX (2001) Neuroimaging studies of ADHD. Stimulant drugs and ADHD: Basic and clinical neuroscience, pp. 243-258. Oxford University Press, New York
10. Chauhan, NB (2003) Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease. J Lipid Res, 44, pp. 2019-2029.
11. Cole, TJ, Bellizzi, MC, Flegal, KM and Dietz, WH (2000) Estabilishing a standard definition for child overweight and obesity worldwide: International survey. BMJ, 320, pp. 1-6.
12. Damsgaard, CT, Schack-Nielsen, L., Michaelsen, KF, Fruekilde, MB, Hels, O. and Lauritzen, L. (2006) Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J Nutr, 136, pp. 94-99.
13. Dey, AN, Shiller, JS and Tai, DA (2002) Summary health statistics for U.S. children: National health interview survey. Vital and Health Stat, 10, p. 221.
14. Elia, J., Ambrosiani, PJ and Rappoport, JL (1999) Treatment of attention-deficit-hyperactivity-disorder. New Engl J Med, 11, pp. 780-788.
15. Fan, YY, McMurray, DN, Ly, LH and Chapkin, RS (2003) Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr, 133, pp. 1913-1920.
16. Folch, J., Lees, M. and Stanley, GH Sloane (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 226, pp. 497-509.
17. Goldman, LS, Genel, M., Bezman, RJ and Slanetz, PJ (1998) Diagnosis and treatment of attention-deficit/hyperactivity-disorder in children and adolescents. JAMA, 279, pp. 1100-1107.
18. Halperin, JM, Newcorn, JH and Schwartz, ST (1993) Plasma catecholamine metabolite levels in ADHD boys with and without reading disabilities. J Clin Child Psycol, 22, pp. 219-225.
19. Hamilton, L., Greiner, R. and Salem Jr, N. (2000) N-3 fatty acid deficency decrease phosphatylserine accumulation selectively in neuronal tissues. Lipids, 35, pp. 863-869.
20. Harbige, LS (2003) Fatty acids, the immune response, and autoimmunity: A question of n-6 essentiality and the balance between n-6 and n-3. Lipids, 38, pp. 323-341.
21. Hashimoto, M., Hossain, S., Agdul, H. and Shido, O. (2005) Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta, 1738, pp. 91-98.
22. Hirayama, S., Hamazaki, T. and Terasawa, K. (2004) Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder: A placebo-controlled double-blind study. Eur J Clin Nutr, 58, pp. 467-473.
23. 17 O NMR. Biophys J, 73, pp. 856-864.
24. Kafrawy, O., Zerouga, M., Stillwell, W. and Jenski, LJ (1998) Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids. Cancer Lett, 132, pp. 23-29.
25. Kang, JX (2003) The importance of omega-6/omega-3 fatty acid ratio in cell function: The gene transfer of omega-3 fatty acid desaturase. World Rev Nutr Diet, 92, pp. 23-36.
26. Koenig, BW, Strey, HH and Gawrisch, K. (1997) Membrane lateral compressibility determined by NMR and X-Ray diffraction: Effect of acyl chain polyunsaturation. Biophys J, 73, pp. 1954-1966.
27. Litman, BJ, Niu, SL, Polozova, A. and Mitchell, DC (2001) The role of docosahexaenoic acid conteining phospholipids in modulating G protein-coupled signaling pathways: Visual transduction. J Mol Neurosci, 16, pp. 237-243.
28. Lobstein, T. and Frelut, ML (2003) Prevalence of overweight among children in Europe. Obes Rev, 4, pp. 195-200.
29. Luciano, A., Bressan, F. and Zoppi, G. (1997) Body mass index reference curves for children aged 3-19 years from Verona, Italy. Eur J Clin Nutr, 51, pp. 6-10.
30. Mayman, GA, Evans, W., Restrepo, H., Hutchins, HL and Sears, B. (2005) Effect of fish oil supplementation on metabolic syndrome and inflammatory parameters during the use of low glycemic load diets in the treatment of pediatric obesity. Communication at annual scientific meeting of American Diabetes Association
31. Millberger, S., Biederman, J., Faraone, SV, Chen, L. and Jones, J. (1996) Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?. Am J Psychiatry, 153, pp. 1138-1142.
32. Mugnaini, D., Masi, G., Brovedani, P., lazzi, C Che, Matas, M., Romagnoli, C. and Zuddas, A. (2005) Teacher reports of ADHD symptoms in Italian children at the end of first grade. Eur Psychiatry
33. Nemets, B., Stahl, Z. and Belmaker, RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry, 159, pp. 477-479.
34. Pearson, S., Stern, S. and Gavack, TH Mc (1953) A rapid accurate method for the determination of total cholesterol. Anal Chem, 25, pp. 313-314.
35. Peet, M. and Horrobin, DF (2002) A dose-ranging study of the effects of ethyl-eicosapentanoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry, 59, pp. 913-919.
36. Pliszka, SR, Maas, JW, Javors, MA, Rogeness, GA and Baker, J. (1994) Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry, 33, pp. 1165-1173.
37. Richardson, AJ (2004) Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins leukot Essent Fatty Acids, 70, pp. 383-390.
38. Richardson, AJ (2004) Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids, 39, pp. 1215-1222.
39. Richardson, AJ and Montgomery, P. (2005) The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115, pp. 1360-1366.
40. Rizzo, AM, Galli, CF, Montorfano, G. and Berra, B. (1995) Phospholipid distribution and fatty acid composition in different brain regions during chick embryo development. J Neurochem, 64, pp. 1728-1733.
41. Ross, BM, McKenzie, I., Glen, I. and Bennett, CP (2003) Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci, 6, pp. 277-281.
42. SanGiovanni, JP and Chew, EY (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res, 24, pp. 87-138.
43. Savani, A. and Nadkarni, A. (1998) Attention deficit disorder, the ADD puzzle & some cognitive behavioral solutions Asian. J Pediatr Pract, 2:2, pp. 45-48.
44. Singh, M. (2005) Essential fatty acids, DHA and human brain. [Review]. Indian J Pediatr, 72, pp. 239-242.
45. Sinopoulos, AP (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother, 56, pp. 365-379.
46. Stevens, LJ, Zentall, SS, Deck, JL, Abate, ML, Watkins, BA, Lipp, SR and Burgess, JR (1995) Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr, 62, pp. 761-768.
47. Stillwell, W. and Wassal, SR (2003) Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem Phys Lipids, 126, pp. 1-27.
48. Swanson, J., Deutsh, C. and Cantwell, D. (2001) Genes and attention-deficit hyperactivity disorder. Clin Neurosci Res, 1, pp. 207-216.
49. Thapar, A., O'Donovan, M. and Owen, MJ (2005) The genetics of attention deficit hyperactivity disorder. [Review]. Hum Mol Genet, 14, pp. R275-R282.
50. Uauy, R., Hoffman, DR, Peirano, P., Birch, DG and Birch, EE (2001) Essential fatty acids in visual and brain development. [Review]. Lipids, 36, pp. 885-895.
51. Vance, DE and Sweeley, CC (1967) Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res, 8, pp. 621-630.
52. Vigh, L., Escriba, PV, Sonnleitner, A., Sonnleitner, M., Piotto, S., Maresca, B., Horvath, I. and Harwood, JL (2005) The significance of lipid composition for membrane activity: New concepts and ways of assessing function. Prog Lipid Res, 44, pp. 303-344.
53. Voigt, RG, Llorente, AM, Jensen, CL, Fraley, JK, Berretta, MC and Heird, WC (2001) A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/ hyperactivity disorder. J Pediatr, 139, pp. 189-196.
54. Wainwright, PE (2002) Dietary essential fatty acids and brain function: A developmental perspective on mechanisms. [Review]. Proc Nutr Soc, 61:1, pp. 61-69.
55. Williams, EE, Jensky, LJ and Stillwell, W. (1998) Docosahexaenoic acid (DHA) alters the structure and composition of membraneous vesicles exfoliated from the surface of a murine leukemia cell line. Biochim Biophys Acta, 1371, pp. 351-362.
56. Yehuda, S., Rabinovitz, S. and Mostofsky, DI (1998) Modulation of learning and neuronal membrane composition in the rat by essential fatty acid preparation: Time-course analysis. Neurochem Res, 23, pp. 627-634.